{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:36:31Z","timestamp":1793504191565,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03511-0","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T04:15:24Z","timestamp":1741320924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Enhanced systemic oxidative stress response in patients with idiopathic inflammatory myopathies"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7590-7318","authenticated-orcid":false,"given":"Anna","family":"Miko\u0142ajczyk-Korona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-3557","authenticated-orcid":false,"given":"Rados\u0142aw","family":"Dziedzic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9786-2499","authenticated-orcid":false,"given":"Krzysztof","family":"W\u00f3jcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3276-7671","authenticated-orcid":false,"given":"Magdalena","family":"Olchawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7693-5756","authenticated-orcid":false,"given":"Tadeusz","family":"Sarna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3527-4768","authenticated-orcid":false,"given":"Jakub","family":"Pi\u0119ta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0444-981X","authenticated-orcid":false,"given":"Bogdan","family":"Jakiela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2221-614X","authenticated-orcid":false,"given":"Lech","family":"Zar\u0119ba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9738-7007","authenticated-orcid":false,"given":"Jan G.","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0324-8506","authenticated-orcid":false,"given":"Daniel P.","family":"Potaczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1013-2253","authenticated-orcid":false,"given":"Joanna","family":"Kosa\u0142ka-W\u0119giel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Socha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2031-6657","authenticated-orcid":false,"given":"Piotr","family":"Kuszmiersz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6492-6521","authenticated-orcid":false,"given":"Agnieszka","family":"Padjas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9634-0963","authenticated-orcid":false,"given":"Stanis\u0142awa","family":"Bazan-Socha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"issue":"2","key":"3511_CR1","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/S2665-9913(23)00322-3","volume":"6","author":"CM Connolly","year":"2024","unstructured":"Connolly CM, Gupta L, Fujimoto M, Machado PM, Paik JJ. Idiopathic inflammatory myopathies: current insights and future frontiers. The Lancet Rheumatology. 2024;6(2):e115\u201327. https:\/\/doi.org\/10.1016\/S2665-9913(23)00322-3.","journal-title":"The Lancet Rheumatology"},{"issue":"1","key":"3511_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","volume":"7","author":"IE Lundberg","year":"2021","unstructured":"Lundberg IE, et al. Idiopathic inflammatory myopathies. Nat Rev Dis Primers. 2021;7(1):86. https:\/\/doi.org\/10.1038\/s41572-021-00321-x.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"3511_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.rdc.2019.07.006","volume":"45","author":"J Vencovsk\u00fd","year":"2019","unstructured":"Vencovsk\u00fd J, Alexanderson H, Lundberg IE. Idiopathic Inflammatory Myopathies. Rheumatic Disease Clinics of North America. 2019;45(4):569\u201381. https:\/\/doi.org\/10.1016\/j.rdc.2019.07.006.","journal-title":"Rheumatic Disease Clinics of North America"},{"issue":"12","key":"3511_CR4","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","volume":"75","author":"K Mariampillai","year":"2018","unstructured":"Mariampillai K, et al. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies. JAMA Neurol. 2018;75(12):1528\u201337. https:\/\/doi.org\/10.1001\/jamaneurol.2018.2598.","journal-title":"JAMA Neurol"},{"issue":"12","key":"3511_CR5","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.17219\/acem\/141181","volume":"30","author":"A Rams","year":"2021","unstructured":"Rams A, et al. Characteristics of idiopathic inflammatory myopathies with novel myositis-specific autoantibodies. Adv Clin Exp Med. 2021;30(12):1239\u201348. https:\/\/doi.org\/10.17219\/acem\/141181.","journal-title":"Adv Clin Exp Med"},{"key":"3511_CR6","doi-asserted-by":"publisher","unstructured":"A. J. Van Der Kooi and M. De Visser, \u201cIdiopathic inflammatory myopathies,\u201d in Handbook of Clinical Neurology, vol. 119, Elsevier, 2014, pp. 495\u2013512. https:\/\/doi.org\/10.1016\/B978-0-7020-4086-3.00032-1.","DOI":"10.1016\/B978-0-7020-4086-3.00032-1"},{"issue":"1","key":"3511_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.12451","volume":"280","author":"Z Betteridge","year":"2016","unstructured":"Betteridge Z, McHugh N. Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med. 2016;280(1):8\u201323. https:\/\/doi.org\/10.1111\/joim.12451.","journal-title":"J Intern Med"},{"issue":"6","key":"3511_CR8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/imj.15358","volume":"51","author":"C Ashton","year":"2021","unstructured":"Ashton C, Paramalingam S, Stevenson B, Brusch A, Needham M. Idiopathic inflammatory myopathies: a review. Intern Med J. 2021;51(6):845\u201352. https:\/\/doi.org\/10.1111\/imj.15358.","journal-title":"Intern Med J"},{"issue":"5","key":"3511_CR9","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.3390\/ijms18051084","volume":"18","author":"D Mandel","year":"2017","unstructured":"Mandel D, Malemud C, Askari A. Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis. IJMS. 2017;18(5):1084. https:\/\/doi.org\/10.3390\/ijms18051084.","journal-title":"IJMS"},{"issue":"3","key":"3511_CR10","doi-asserted-by":"publisher","first-page":"e12955","DOI":"10.1111\/bpa.12955","volume":"31","author":"L Bolko","year":"2021","unstructured":"Bolko L, et al. The role of interferons type I, II and III in myositis: A review. Brain Pathol. 2021;31(3):e12955. https:\/\/doi.org\/10.1111\/bpa.12955.","journal-title":"Brain Pathol"},{"issue":"5","key":"3511_CR11","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/bjd.15006","volume":"176","author":"C Huard","year":"2017","unstructured":"Huard C, Gull\u00e0 SV, Bennett DV, Coyle AJ, Vleugels RA, Greenberg SA. Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon \u03b2 in dermatomyositis. Br J Dermatol. 2017;176(5):1224\u201330. https:\/\/doi.org\/10.1111\/bjd.15006.","journal-title":"Br J Dermatol"},{"issue":"3","key":"3511_CR12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11926-010-0101-6","volume":"12","author":"SA Greenberg","year":"2010","unstructured":"Greenberg SA. Dermatomyositis and Type 1 Interferons. Curr Rheumatol Rep. 2010;12(3):198\u2013203. https:\/\/doi.org\/10.1007\/s11926-010-0101-6.","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"3511_CR13","doi-asserted-by":"publisher","first-page":"e1193","DOI":"10.1212\/WNL.0000000000008128","volume":"93","author":"I Pinal-Fernandez","year":"2019","unstructured":"Pinal-Fernandez I, et al. Identification of distinctive interferon gene signatures in different types of myositis. Neurology. 2019;93(12):e1193\u2013204. https:\/\/doi.org\/10.1212\/WNL.0000000000008128.","journal-title":"Neurology."},{"issue":"1","key":"3511_CR14","doi-asserted-by":"publisher","first-page":"e000811","DOI":"10.1136\/rmdopen-2018-000811","volume":"5","author":"M Rigolet","year":"2019","unstructured":"Rigolet M, et al. Distinct interferon signatures stratify inflammatory and dysimmune myopathies. RMD Open. 2019;5(1):e000811. https:\/\/doi.org\/10.1136\/rmdopen-2018-000811.","journal-title":"RMD Open"},{"key":"3511_CR15","doi-asserted-by":"publisher","unstructured":"Aouizerate J. et al.\u00a0\u201cMyofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy\u201d. acta neuropathol commun.\u00a02014;2(1)154. https:\/\/doi.org\/10.1186\/s40478-014-0154-2.","DOI":"10.1186\/s40478-014-0154-2"},{"issue":"3","key":"3511_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s11926-996-0024-4","volume":"8","author":"C Grundtman","year":"2006","unstructured":"Grundtman C, Lundberg IE. Pathogenesis of idiopathic inflammatory myopathies. Curr Rheumatol Rep. 2006;8(3):188\u201395. https:\/\/doi.org\/10.1007\/s11926-996-0024-4.","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"3511_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1046\/j.1365-2249.1998.00664.x","volume":"113","author":"K Nagaraju","year":"2001","unstructured":"Nagaraju K, Raben N, Merritt G, Loeffler L, Kirk K, Plotz P. A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli. Clin Exp Immunol. 2001;113(3):407\u201314. https:\/\/doi.org\/10.1046\/j.1365-2249.1998.00664.x.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"3511_CR18","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00401-021-02365-5","volume":"142","author":"DR Amici","year":"2021","unstructured":"Amici DR, Pinal-Fernandez I, Christopher-Stine L, Mammen AL, Mendillo ML. A network of core and subtype-specific gene expression programs in myositis. Acta Neuropathol. 2021;142(5):887\u201398. https:\/\/doi.org\/10.1007\/s00401-021-02365-5.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"3511_CR19","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20020186","volume":"196","author":"OMZ Howard","year":"2002","unstructured":"Howard OMZ, et al. Histidyl\u2013tRNA Synthetase and Asparaginyl\u2013tRNA Synthetase, Autoantigens in Myositis, Activate Chemokine Receptors on T Lymphocytes and Immature Dendritic Cells. J Exp Med. 2002;196(6):781\u201391. https:\/\/doi.org\/10.1084\/jem.20020186.","journal-title":"J Exp Med"},{"issue":"9","key":"3511_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0167-5699(95)80023-9","volume":"16","author":"J-P Girard","year":"1995","unstructured":"Girard J-P, Springer TA. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today. 1995;16(9):449\u201357. https:\/\/doi.org\/10.1016\/0167-5699(95)80023-9.","journal-title":"Immunol Today"},{"issue":"6","key":"3511_CR21","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1172\/JCI116122","volume":"90","author":"R Shreeniwas","year":"1992","unstructured":"Shreeniwas R, et al. Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest. 1992;90(6):2333\u20139. https:\/\/doi.org\/10.1172\/JCI116122.","journal-title":"J Clin Invest"},{"issue":"6","key":"3511_CR22","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1002\/art.21103","volume":"52","author":"K Nagaraju","year":"2005","unstructured":"Nagaraju K, et al. Activation of the endoplasmic reticulum stress response in autoimmune myositis: Potential role in muscle fiber damage and dysfunction. Arthritis Rheum. 2005;52(6):1824\u201335. https:\/\/doi.org\/10.1002\/art.21103.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3511_CR23","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.3390\/ijms25063360","volume":"25","author":"T Yoshikawa","year":"2024","unstructured":"Yoshikawa T, You F. Oxidative Stress and Bio-Regulation. IJMS. 2024;25(6):3360. https:\/\/doi.org\/10.3390\/ijms25063360.","journal-title":"IJMS"},{"issue":"11","key":"3511_CR24","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1096\/fj.02-0134fje","volume":"16","author":"P Salven","year":"2002","unstructured":"Salven P, Hattori K, Heissig B, Rafii S. Interleukin-1\u03b1 (IL-1\u03b1) promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion. FASEB j. 2002;16(11):1471\u20133. https:\/\/doi.org\/10.1096\/fj.02-0134fje.","journal-title":"FASEB j"},{"issue":"3","key":"3511_CR25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1006\/clin.1998.4527","volume":"87","author":"DS Tews","year":"1998","unstructured":"Tews DS, Goebel HH. Cell Death and Oxidative Damage in Inflammatory Myopathies. Clin Immunol Immunopathol. 1998;87(3):240\u20137. https:\/\/doi.org\/10.1006\/clin.1998.4527.","journal-title":"Clin Immunol Immunopathol"},{"issue":"7","key":"3511_CR26","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2014-207172","volume":"74","author":"AP Lightfoot","year":"2015","unstructured":"Lightfoot AP, McArdle A, Jackson MJ, Cooper RG. In the idiopathic inflammatory myopathies (IIM), do reactive oxygen species (ROS) contribute to muscle weakness? Ann Rheum Dis. 2015;74(7):1340\u20136. https:\/\/doi.org\/10.1136\/annrheumdis-2014-207172.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3511_CR27","doi-asserted-by":"publisher","first-page":"103308","DOI":"10.1016\/j.autrev.2023.103308","volume":"22","author":"MG Danieli","year":"2023","unstructured":"Danieli MG, Antonelli E, Piga MA, Cozzi MF, Allegra A, Gangemi S. Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies. Autoimmun Rev. 2023;22(5):103308. https:\/\/doi.org\/10.1016\/j.autrev.2023.103308.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"3511_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41584-019-0186-x","volume":"15","author":"SA Greenberg","year":"2019","unstructured":"Greenberg SA. Inclusion body myositis: clinical features and pathogenesis. Nat Rev Rheumatol. 2019;15(5):257\u201372. https:\/\/doi.org\/10.1038\/s41584-019-0186-x.","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"3511_CR29","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1093\/rheumatology\/keaa273","volume":"59","author":"SS Bae","year":"2020","unstructured":"Bae SS, et al. High- density lipoprotein function is abnormal in idiopathic inflammatory myopathies. Rheumatology. 2020;59(11):3515\u201325. https:\/\/doi.org\/10.1093\/rheumatology\/keaa273.","journal-title":"Rheumatology"},{"issue":"3","key":"3511_CR30","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/rheumatology\/keac429","volume":"62","author":"W Huang","year":"2023","unstructured":"Huang W, et al. Evaluating the value of superoxide dismutase in anti-MDA5-positive dermatomyositis associated with interstitial lung disease. Rheumatology. 2023;62(3):1197\u2013203. https:\/\/doi.org\/10.1093\/rheumatology\/keac429.","journal-title":"Rheumatology"},{"issue":"7","key":"3511_CR31","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1080\/00207454.2016.1220380","volume":"127","author":"Z Chen","year":"2017","unstructured":"Chen Z, et al. Antioxidant status of serum bilirubin and uric acid in patients with polymyositis and dermatomyositis. Int J Neurosci. 2017;127(7):617\u201323. https:\/\/doi.org\/10.1080\/00207454.2016.1220380.","journal-title":"Int J Neurosci"},{"issue":"32","key":"3511_CR32","doi-asserted-by":"publisher","first-page":"22536","DOI":"10.1074\/jbc.M114.553727","volume":"289","author":"R Michalski","year":"2014","unstructured":"Michalski R, Zielonka J, Gapys E, Marcinek A, Joseph J, Kalyanaraman B. Real-time Measurements of Amino Acid and Protein Hydroperoxides Using Coumarin Boronic Acid. J Biol Chem. 2014;289(32):22536\u201353. https:\/\/doi.org\/10.1074\/jbc.M114.553727.","journal-title":"J Biol Chem"},{"issue":"7","key":"3511_CR33","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and Dermatomyositis: (First of Two Parts). N Engl J Med. 1975;292(7):344\u20137. https:\/\/doi.org\/10.1056\/NEJM197502132920706.","journal-title":"N Engl J Med"},{"issue":"8","key":"3511_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and Dermatomyositis: (Second of Two Parts). N Engl J Med. 1975;292(8):403\u20137. https:\/\/doi.org\/10.1056\/NEJM197502202920807.","journal-title":"N Engl J Med"},{"issue":"12","key":"3511_CR35","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, et al. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76(12):1955\u201364. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"3511_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nrrheum.2018.33","volume":"14","author":"LG Rider","year":"2018","unstructured":"Rider LG, et al. Update on outcome assessment in myositis. Nat Rev Rheumatol. 2018;14(5):303\u201318. https:\/\/doi.org\/10.1038\/nrrheum.2018.33.","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"3511_CR37","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1002\/art.21291","volume":"52","author":"CV Oddis","year":"2005","unstructured":"Oddis CV, et al. International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies. Arthritis Rheum. 2005;52(9):2607\u201315. https:\/\/doi.org\/10.1002\/art.21291.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3511_CR38","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/rheumatology\/kex226","volume":"56","author":"LG Rider","year":"2017","unstructured":"Rider LG, et al. 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria\u2014methodological aspects. Rheumatology. 2017;56(11):1884\u201393. https:\/\/doi.org\/10.1093\/rheumatology\/kex226.","journal-title":"Rheumatology"},{"issue":"16","key":"3511_CR39","doi-asserted-by":"publisher","first-page":"5830","DOI":"10.3390\/ijms21165830","volume":"21","author":"A Mensch","year":"2020","unstructured":"Mensch A, Zierz S. Cellular Stress in the Pathogenesis of Muscular Disorders\u2014From Cause to Consequence. IJMS. 2020;21(16):5830. https:\/\/doi.org\/10.3390\/ijms21165830.","journal-title":"IJMS"},{"key":"3511_CR40","doi-asserted-by":"publisher","first-page":"940122","DOI":"10.3389\/fimmu.2022.940122","volume":"13","author":"EG Corona-Sanchez","year":"2022","unstructured":"Corona-Sanchez EG, et al. Autoantibodies in the pathogenesis of idiopathic inflammatory myopathies: Does the endoplasmic reticulum stress response have a role? Front Immunol. 2022;13:940122. https:\/\/doi.org\/10.3389\/fimmu.2022.940122.","journal-title":"Front Immunol"},{"issue":"13","key":"3511_CR41","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1242\/jcs.080762","volume":"124","author":"R Bravo","year":"2011","unstructured":"Bravo R, et al. Increased ER\u2013mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress. J Cell Sci. 2011;124(13):2143\u201352. https:\/\/doi.org\/10.1242\/jcs.080762.","journal-title":"J Cell Sci"},{"key":"3511_CR42","doi-asserted-by":"publisher","unstructured":"Gilbert HF. Thiol\/disulfide exchange equilibria and disulfide bond stability. Methods Enzymol. 1995;251:8\u201328. https:\/\/doi.org\/10.1016\/0076-6879(95)51107-5.","DOI":"10.1016\/0076-6879(95)51107-5"},{"issue":"5","key":"3511_CR43","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.molcel.2004.08.025","volume":"15","author":"CM Haynes","year":"2004","unstructured":"Haynes CM, Titus EA, Cooper AA. Degradation of Misfolded Proteins Prevents ER-Derived Oxidative Stress and Cell Death. Mol Cell. 2004;15(5):767\u201376. https:\/\/doi.org\/10.1016\/j.molcel.2004.08.025.","journal-title":"Mol Cell"},{"issue":"7","key":"3511_CR44","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.3390\/biomedicines10071499","volume":"10","author":"S Bazan-Socha","year":"2022","unstructured":"Bazan-Socha S, et al. Increased Oxidative Stress in Asthma\u2014Relation to Inflammatory Blood and Lung Biomarkers and Airway Remodeling Indices. Biomedicines. 2022;10(7):1499. https:\/\/doi.org\/10.3390\/biomedicines10071499.","journal-title":"Biomedicines"},{"key":"3511_CR45","doi-asserted-by":"publisher","first-page":"152228","DOI":"10.1016\/j.semarthrit.2023.152228","volume":"62","author":"R Dziedzic","year":"2023","unstructured":"Dziedzic R, et al. Increased oxidative stress response in circulating blood of systemic sclerosis patients \u2013 relation to disease characteristics and inflammatory blood biomarkers. Semin Arthritis Rheum. 2023;62:152228. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152228.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03511-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03511-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03511-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T09:13:03Z","timestamp":1742807583000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03511-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3511"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03511-0","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"26 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The supplementary material was missing in the published article. This is now added.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The following research provides single-center data and has a case\u2013control type, and was approved by the Bioethics Committee of the Jagiellonian University Medical College (permit No: 1072.6120.200.2021). The study procedures were carried out under the ethical guidelines of the Declaration of Helsinki. All participants gave informed consent in writing to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants were informed that data obtained during study will be published. Thus, the study could be further published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}